HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3- benzyl- 7- (2- oxazolyl)thio- 1,2,3- triazolo(4,5- d)pyrimidine

structure in first source

Also Known As:

VAS 3947; VAS-3947; VAS3947

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Triazoles: 1533
      - 3-benzyl-7-(2-oxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine: 2
  - Pyrimidines: 510
    - 3-benzyl-7-(2-oxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine: 2

Experts

1.	Chen, Ray Jade: 1 article (12/2019)
2.	Huang, Li Ting: 1 article (12/2019)
3.	Lee, Tzu Yin: 1 article (12/2019)
4.	Li, Jiun Yi: 1 article (12/2019)
5.	Lin, Kuan Hung: 1 article (12/2019)
6.	Lu, Wan Jung: 1 article (12/2019)
7.	Almeida, Michael F: 1 article (01/2019)
8.	Bahnson, Edward M: 1 article (01/2019)
9.	Bahr, Ben A: 1 article (01/2019)
10.	Grant, Ruriko: 1 article (01/2019)

Related Diseases

1.	Thrombosis (Thrombus) 12/11/2019 - "VAS2870 and VAS3947 attenuate platelet activation and thrombus formation via a NOX-independent pathway downstream of PKC."
2.	Cardiomyopathies (Cardiomyopathy) 01/01/2019 - "In contrast, a pan-NADPH oxidase inhibitor, VAS3947, markedly prevented cardiomyopathy. "

Related Drugs and Biologics

1.	NADPH Oxidases (NAD(P)H oxidase)
2.	3- benzyl- 7- (2- benzoxazolyl)thio- 1,2,3- triazolo(4,5- d)pyrimidine